Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings

The burden of depression significantly impacts the patient, the health care system, and society, at large. Medication management guided by pharmacogenetics has been shown to increase therapeutic efficacy and improve symptoms in patients diagnosed with depression, but limited data are available on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Maciel, Alejandra, Cullors, Ali, Lukowiak, Andrew A, Garces, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764291/
https://www.ncbi.nlm.nih.gov/pubmed/29386895
http://dx.doi.org/10.2147/NDT.S145046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764291/
https://www.ncbi.nlm.nih.gov/pubmed/29386895
http://dx.doi.org/10.2147/NDT.S145046

Ejemplares similares